LIPHATECH S.A. – Trademark Portfolio

Entity Type: 03

LIPHATECH S.A. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LIPHATECH and GENERATION. The owner is based in FONTENAY-SOUS-BOIS.

201 RUE CARNOT

FONTENAY-SOUS-BOIS 94120 , FR

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LIFT
LIFT
Cancelled 1994
LIPHATECH
LIPHATECH
Registered 1990

Trademark Classifications

LIPHATECH S.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does LIPHATECH S.A. have?

LIPHATECH S.A. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does LIPHATECH S.A. file in?

LIPHATECH S.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are LIPHATECH S.A.'s most well-known trademarks?

LIPHATECH S.A.'s registered trademark portfolio includes well-known marks such as LIPHATECH and GENERATION. These are among 2 currently registered trademarks in the portfolio.

What is LIPHATECH S.A.'s trademark registration success rate?

LIPHATECH S.A. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.